Literature DB >> 7943023

Evaluation of school children at high risk for fragile X syndrome utilizing buccal cell FMR-1 testing.

R J Hagerman1, P Wilson, L W Staley, K A Lang, T Fan, C Uhlhorn, S Jewell-Smart, C Hull, J Drisko, K Flom.   

Abstract

We describe a pilot project utilizing saliva to identify the FMR-1 mutation in high-risk special education students from four public school districts in Colorado. The program included presentations to special education teachers regarding fragile X syndrome, parental consent for testing, completion of a behavior checklist by the teachers, identification of special education students at high risk for fragile X syndrome, subsequent brief examination of face and hands, collection of a saliva sample by either Gatorade swish or brushing of the inside of the cheek, and analysis for the FMR-1 mutation by PCR. Equivocal samples were studied by direct DNA testing using Southern blot analysis, and abnormal results were confirmed by a blood analysis for the FMR-1 mutation. Mutant individuals received genetic counseling and medical and educational assessments to optimize treatment and intervention. This pilot project was met with enthusiasm by the schools. Of the first 439 students evaluated, 68% were male with an average age of 7.75 years; 13% were mentally retarded or autistic. Most students referred for the evaluation were learning disabled (51%) and/or had an Attention Deficit Hyperactivity Disorder (ADHD) (35%). The overall prevalence of the FMR-1 mutation was 5 of 439 or 1.1%. This relatively low yield is probably due to the high number of non-retarded but learning disabled students tested. Of the mentally retarded patients tested, 3.5% were positive for the FMR-1 mutation; however, of the non-retarded or learning disabled patients, only 0.79% were FMR-1 positive.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943023     DOI: 10.1002/ajmg.1320510436

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  The commercialization of clinical genetics: an analysis of interrelations between academic centers and for-profit clinical genetics diagnostics companies.

Authors:  Marvin R Natowicz; Catherine Ard
Journal:  J Genet Couns       Date:  1997-09       Impact factor: 2.537

2.  Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group.

Authors:  B B de Vries; A M van den Ouweland; S Mohkamsing; H J Duivenvoorden; E Mol; K Gelsema; M van Rijn; D J Halley; L A Sandkuijl; B A Oostra; A Tibben; M F Niermeijer
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori.

Authors:  Xiao-Feng Luo; Jian-Hua Jiao; Wen-Yue Zhang; Han-Ming Pu; Bao-Jin Qu; Bing-Ya Yang; Min Hou; Min-Jun Ji
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 4.  Fragile X syndrome.

Authors:  J P Phillips; G A Wilson
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

5.  Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group.

Authors:  B B de Vries; S Mohkamsing; A M van den Ouweland; E Mol; K Gelsema; M van Rijn; A Tibben; D J Halley; H J Duivenvoorden; B A Oostra; M F Niermeijer
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

6.  DNA testing for fragile X syndrome in schools for learning difficulties.

Authors:  S F Slaney; A O Wilkie; M C Hirst; R Charlton; M McKinley; J Pointon; Z Christodoulou; S M Huson; K E Davies
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

Review 7.  The fragile X syndrome.

Authors:  B B de Vries; D J Halley; B A Oostra; M F Niermeijer
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

Review 8.  FMR1 and the fragile X syndrome: human genome epidemiology review.

Authors:  D C Crawford; J M Acuña; S L Sherman
Journal:  Genet Med       Date:  2001 Sep-Oct       Impact factor: 8.822

9.  Cascade Screening for Fragile X Syndrome/CGG Repeat Expansions in Children Attending Special Education in Sri Lanka.

Authors:  C H W M R Bhagya Chandrasekara; W S Sulochana Wijesundera; Hemamali N Perera; Samuel S Chong; Indhu-Shree Rajan-Babu
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.